Overview

Montu operates an Australian health-technology ecosystem for medical cannabis, linking patients, doctors, and pharmacies. Its products include Alternaleaf, a telehealth clinic where patients can get medical cannabis prescriptions online, and Montu Medical, a platform with tools for healthcare professionals to prescribe cannabis; it also handles supply and distribution as a major supplier. Unlike many players, Montu combines patient access, clinician prescribing tools, and an end-to-end supply chain in one platform. Its goal is to improve access to medical cannabis in Australia through an integrated solution, while expanding its supplier role amid regulatory scrutiny.

Simplify's Take

What believers are saying

• Australian market hits A$1.4B by 2025, boosting Montu growth.
• UK Alternaleaf launch taps 50% CAGR sector, 1.4M patients.
• Tambassis appointment strengthens pharmacy ties, regulatory navigation.

What critics are saying

• TGA fines Montu $627k for unlawful advertising, restricts operations.
• Curaleaf buys UKMC for £21.5M, blocks Alternaleaf patient base.
• TGA bans Schedule 4 ads, shuts Alternaleaf, drops 80% acquisitions.

What makes Montu unique

• Montu integrates Alternaleaf telehealth with Montu Medical clinician platform.
• Montu leads Australia as largest medical cannabis supplier via dispensing-as-a-service.
• Montu connects patients, doctors, pharmacies in end-to-end ecosystem.

Help us improve and share your feedback! Did you find this helpful?

YesNo